Tirzepatide
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
Eli Lilly · Phase 3 · Completed · Enrollment 731
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Tirzepatide | 62 participants | 38 participants | 65 participants | n/r | 19 |
| Placebo | 23 participants | 7 participants | 23 participants | n/r | 15 |
A count stays a count. This page does not turn a count into a percent.